InvestorsObserver gives Merck & Co., Inc. (MRK) a strong valuation score of 89 from its analysis. The proprietary scoring system considers the underlying health of a company by analyzing its stock price, earnings, and growth rate. MRK currently holds a better value than 89% of stocks based on these metrics. Long term investors focused on buying-and-holding should find the valuation ranking system most relevant when making investment decisions.
MRK's 12-month-forward PE to Growth (PEG) ratio of 1.16 is considered a roughly average value as the market is valuing MRK right in line with its projected earnings growth. MRK's PEG comes from its forward price to earnings ratio being divided by its growth rate. A PEG ratio of 1 represents a perfect correlation between earnings growth and share price. Due to their incorporation of more fundamentals of a company's overall health and focusing on the future rather than the past, PEG ratios are one of the most used valuation metrics by analysts today.
Should You Buy Merck & Co., Inc. (MRK) Stock Wednesday?
MRK gets a 89 Valuation Rank today. Find out what this means to you and get the rest of the rankings on MRK!